Insider filing · AXGN
Joseph A. Tyndall
Director
profile →
Axogen, Inc.
AXGN · Healthcare · 30 filings in 24 months
ticker →
Joseph A. Tyndall sold $778K of Axogen (AXGN)
Executed Dec 9 2025, disclosed Dec 10 2025, 1 day later.
Value, as filed
$778K
25,108 sh across 2 lots
Executed
Dec 9 2025
the trade date, as filed
Disclosed
Dec 10 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JTJoseph A. Tyndall (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Axogen, Inc. (AXGN). The largest single filing was $778K of AXGN (25,108 sh across 2 lots, as filed), executed Dec 9 2025.
The name
AXGNHealthcare · Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerv…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Joseph A. Tyndall in AXGN
AXGNSALE
Axogen, Inc.
$174K3,500 sh × $49.70
Exec Sep 2
Filed Sep 4 · 4:08 PM ET AXGNSALE Axogen, Inc. $289K
26,931 sh × $10.72
Exec Jun 10 2025
Filed Jun 11 2025 · 5:30 PM ET AXGNSALE Axogen, Inc. $144K
12,850 sh × $11.20
Exec May 22 2025
Filed May 23 2025 · 5:30 PM ET